Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-90,095
Closed -$4.68M 30
2024
Q1
$4.68M Hold
90,095
0.51% 25
2023
Q4
$3.96M Sell
90,095
-286,475
-76% -$13.1M 0.49% 22
2023
Q3
$17.9M Buy
376,570
+32,060
+9% +$1.45M 2.44% 16
2023
Q2
$13.1M Hold
344,510
1.99% 17
2023
Q1
$12.4M Buy
344,510
+12,500
+4% +$551K 2.11% 16
2022
Q4
$16.8M Buy
332,010
+35,685
+12% +$1.86M 2.92% 15
2022
Q3
$13.6M Buy
+296,325
New +$14.2M 2.28% 15

Other funds holding OVV

Progeny 3 Inc's OVV Position: Q2 2024 in Review

Progeny 3 Inc sold out of Ovintiv (OVV) in Q2 2024, closing a stake of 90,095 shares — an estimated $4.68M sold.

Progeny 3 Inc first reported a position in OVV in Q3 2022 and held it in 7 quarters. The position peaked at $17.9M in Q3 2023. 548 funds tracked by Wall St. Rank hold OVV as of Q2 2024.

  • Progeny 3 Inc reported no remaining Ovintiv position as of Q2 2024 after selling out during the quarter.
  • Progeny 3 Inc sold 90,095 Ovintiv shares in Q2 2024, an estimated $4.68M.
  • Progeny 3 Inc first reported a position in Ovintiv in Q3 2022 and held it in 7 quarters.
  • Progeny 3 Inc's Ovintiv position peaked at $17.9M in Q3 2023.
  • 548 funds tracked by Wall St. Rank held Ovintiv as of Q2 2024.

Based on Progeny 3 Inc's 13F filing for Q2 2024, filed 14 Aug 2024.